Achaogen MAA to EMA for potential Approval of Plazomicin received the 120 day questions; expects to reply by May 24. Bidding wars have begun, expecting well north of $150 million. ZEMDRI in the right hands will reap rewards as exclusivity extends beyond 2032. Lots of money can be made here depending sale price while bidding process heats up
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.